DK174400B1 - Acylderivater af deoxyribonucleosider og farmaceutiske præparater indeholdende disse - Google Patents
Acylderivater af deoxyribonucleosider og farmaceutiske præparater indeholdende disse Download PDFInfo
- Publication number
- DK174400B1 DK174400B1 DK198903180A DK318089A DK174400B1 DK 174400 B1 DK174400 B1 DK 174400B1 DK 198903180 A DK198903180 A DK 198903180A DK 318089 A DK318089 A DK 318089A DK 174400 B1 DK174400 B1 DK 174400B1
- Authority
- DK
- Denmark
- Prior art keywords
- acid
- acyl
- carbon atoms
- derivatives
- deoxyribonucleosides
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/06—Pyrimidine radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
- A61K31/7072—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
- A61K31/708—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid having oxo groups directly attached to the purine ring system, e.g. guanosine, guanylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/06—Pyrimidine radicals
- C07H19/10—Pyrimidine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Dermatology (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Cosmetics (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11592387A | 1987-10-28 | 1987-10-28 | |
US11592387 | 1987-10-28 | ||
PCT/US1988/003824 WO1989003838A1 (en) | 1987-10-28 | 1988-10-27 | Acyl deoxyribonucleoside derivatives and uses thereof |
US8803824 | 1988-10-27 |
Publications (3)
Publication Number | Publication Date |
---|---|
DK318089D0 DK318089D0 (da) | 1989-06-27 |
DK318089A DK318089A (da) | 1989-08-28 |
DK174400B1 true DK174400B1 (da) | 2003-02-10 |
Family
ID=22364166
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK198903180A DK174400B1 (da) | 1987-10-28 | 1989-06-27 | Acylderivater af deoxyribonucleosider og farmaceutiske præparater indeholdende disse |
Country Status (15)
Country | Link |
---|---|
US (1) | US6020320A (it) |
EP (2) | EP0355131B1 (it) |
JP (2) | JP2637534B2 (it) |
KR (1) | KR890701609A (it) |
AT (2) | ATE243039T1 (it) |
CA (1) | CA1329932C (it) |
DE (2) | DE3855513T2 (it) |
DK (1) | DK174400B1 (it) |
FI (2) | FI91764C (it) |
HK (1) | HK1004854A1 (it) |
IL (1) | IL88204A (it) |
IN (1) | IN167609B (it) |
NO (1) | NO174392C (it) |
WO (1) | WO1989003838A1 (it) |
ZA (1) | ZA888083B (it) |
Families Citing this family (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7776838B1 (en) | 1987-10-28 | 2010-08-17 | Wellstat Therapeutics Corporation | Treatment of chemotherapeutic agent and antiviral agent toxicity with acylated pyrimidine nucleosides |
US6743782B1 (en) * | 1987-10-28 | 2004-06-01 | Wellstat Therapeutics Corporation | Acyl deoxyribonucleoside derivatives and uses thereof |
US5736531A (en) * | 1987-10-28 | 1998-04-07 | Pro-Neuron, Inc. | Compositions of chemotherapeutic agent or antiviral agent with acylated pyrimidine nucleosides |
US5470838A (en) | 1987-10-28 | 1995-11-28 | Pro-Neuron, Inc. | Method of delivering exogenous uridine or cytidine using acylated uridine or cytidine |
US6329350B1 (en) * | 1987-10-28 | 2001-12-11 | Pro-Neuron, Inc. | Pyrimidine nucleotide precursors for treatment of systemic inflammation and inflammatory hepatitis |
US6054441A (en) | 1987-10-28 | 2000-04-25 | Pro-Neuron, Inc. | Oxypurine nucleosides and their congeners, and acyl derivatives thereof, for improvement of hematopoiesis |
US5968914A (en) * | 1987-10-28 | 1999-10-19 | Pro-Neuron, Inc. | Treatment of chemotherapeutic agent and antiviral agent toxicity with acylated pyrimidine nucleosides |
US5691320A (en) * | 1987-10-28 | 1997-11-25 | Pro-Neuron, Inc. | Acylated pyrimidine nucleosides for treatment of systemic inflammation and inflammatory hepatitis |
IE980216A1 (en) * | 1989-04-17 | 2000-02-23 | Scotia Holdings Plc | Anti-virals |
IL100874A (en) * | 1991-02-08 | 1996-01-19 | Pro Neuron Inc | Oxiforin nucleosides and their composition, for use as medicines, their preparation and pharmaceutical preparations containing them |
DE69232070T2 (de) * | 1991-07-05 | 2002-06-06 | Pro-Neuron, Inc. | Behandlung der toxischen wirkung von chemotherapeutischen und antiviralen wirkstoffen mit acylierten pyrimidinnukleosiden |
GB2260319B (en) * | 1991-10-07 | 1995-12-06 | Norsk Hydro As | Acyl derivatives of nucleosides and nucleoside analogues having anti-viral activity |
CA2150940C (en) * | 1992-12-08 | 2007-08-21 | Reid Warren Von Borstel | Pyrimidine nucleotide precursors for treatment of systemic inflammation and inflammatory hepatitis |
US5641758A (en) * | 1993-11-10 | 1997-06-24 | Kluge; Michael | Cytarabine derivatives, the preparation and use thereof |
EP0768883A4 (en) | 1994-07-01 | 2004-09-15 | Wellstat Therapeutics Corp | PYRIMIDINE NUCLEOTIDE PRECURSORS FOR THE TREATMENT OF SYSTEMIC INFLAMMATION AND INFLAMMATORY HEPATITIS |
EP0882734B1 (en) * | 1997-06-02 | 2009-08-26 | F. Hoffmann-La Roche Ag | 5'-Deoxy-cytidine derivatives |
US20020006913A1 (en) | 1997-11-04 | 2002-01-17 | Von Borstel Reid W. | Antimutagenic compositions for treatment and prevention of photodamage to skin |
WO1999030705A1 (en) * | 1997-12-16 | 1999-06-24 | William Darwin Garner | Reduction of uv induced skin cancer by topical amines |
US6444652B1 (en) | 1998-08-10 | 2002-09-03 | Novirio Pharmaceuticals Limited | β-L-2'-deoxy-nucleosides for the treatment of hepatitis B |
CA2340156C (en) | 1998-08-10 | 2007-10-23 | Novirio Pharmaceuticals Limited | .beta.-l-2'-deoxy-nucleosides for the treatment of hepatitis b |
RU2268732C2 (ru) | 1999-02-23 | 2006-01-27 | Дзе Риджентс Оф Дзе Юниверсити Оф Калифорния | Способы лечения митохондриальных нарушений |
US6576619B2 (en) * | 1999-05-24 | 2003-06-10 | Cv Therapeutics, Inc. | Orally active A1 adenosine receptor agonists |
US6787526B1 (en) | 2000-05-26 | 2004-09-07 | Idenix Pharmaceuticals, Inc. | Methods of treating hepatitis delta virus infection with β-L-2′-deoxy-nucleosides |
US6875751B2 (en) | 2000-06-15 | 2005-04-05 | Idenix Pharmaceuticals, Inc. | 3′-prodrugs of 2′-deoxy-β-L-nucleosides |
DE10117615A1 (de) * | 2001-04-07 | 2002-10-10 | Max Delbrueck Centrum | Verwendung von Nucleosiden, Nucleobasen und deren Derivaten zur verbesserten Gewinnung von adulten Stammzellen |
TWI244393B (en) | 2002-08-06 | 2005-12-01 | Idenix Pharmaceuticals Inc | Crystalline and amorphous forms of beta-L-2'-deoxythymidine |
KR100855907B1 (ko) | 2002-09-13 | 2008-09-02 | 노파르티스 아게 | 내성 HBV 균주 치료용 β-L-2'-데옥시뉴클레오시드 및병용 요법 |
WO2009045655A2 (en) | 2007-08-16 | 2009-04-09 | The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. | Compositions containing purine nucleosides and manganese and their uses |
CA2751563A1 (en) * | 2009-02-04 | 2010-08-12 | Jelena Mann | Methods of inhibiting fibrogenesis and treating fibrotic disease |
BR112012027740B1 (pt) | 2010-04-29 | 2021-02-17 | The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. | composições contendo nucleosídeos de purina e pirimidina, peptídeos e maganês e seus usos |
US9446064B2 (en) | 2013-03-14 | 2016-09-20 | Epizyme, Inc. | Combination therapy for treating cancer |
AU2021202658A1 (en) | 2021-04-28 | 2022-11-17 | Fondazione Telethon | Gene therapy |
Family Cites Families (37)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3847898A (en) * | 1969-05-27 | 1974-11-12 | Upjohn Co | N4-trihaloethoxy carbonyl arabino-furanosyl cytosine 5'-esters |
US3585188A (en) * | 1969-06-16 | 1971-06-15 | Takeda Chemical Industries Ltd | Process for producing 2'-deoxyuridine |
DE1941942A1 (de) * | 1969-08-18 | 1971-03-04 | Sylven Bengt Prof Dr | Neues pharmazeutisches Mittel |
FR2096712A1 (en) * | 1970-06-29 | 1972-02-25 | Giraux Georges | Steroid/b group vitamin compsns - for prevention and treatment of skin-photosensitivity disorders |
US3894000A (en) * | 1971-01-27 | 1975-07-08 | Upjohn Co | Ara-cytidine derivatives and process of preparation |
US3975367A (en) * | 1971-06-08 | 1976-08-17 | The Upjohn Company | Arabinofuranosyl N4 -aminoacyl cytosine containing compounds |
DE2147094A1 (de) * | 1971-09-21 | 1973-04-05 | Robugen Gmbh | Virostatisch wirksames arzneimittel |
US3991045A (en) * | 1973-05-30 | 1976-11-09 | Asahi Kasei Kogyo Kabushiki Kaisha | N4 -acylarabinonucleosides |
US4048432A (en) * | 1976-05-17 | 1977-09-13 | Parke, Davis & Company | 9-(3,5-Di-O-acyl-β-D-arabinofuranosyl)adenine compounds and method for their production |
FR2358155A1 (fr) * | 1976-07-15 | 1978-02-10 | Lapinet Eugene | Composition pour le traitement et la prevention de l'irritation et de l'inflammation de la peau, de l'oeil et des muqueuses |
US4675189A (en) * | 1980-11-18 | 1987-06-23 | Syntex (U.S.A.) Inc. | Microencapsulation of water soluble active polypeptides |
JPS5791994A (en) * | 1980-11-26 | 1982-06-08 | Fuji Kagaku Kogyo Kk | 5'-o-(n-alkylcarbamoylalanyl)-5-fluorouridine and its preparation |
DE3100478A1 (de) | 1981-01-09 | 1982-08-12 | Dr. Thilo & Co GmbH, 8021 Sauerlach | 5'ester von pyrimidinnucleosiden mit antiviraler wirksamkeit, verfahren zur herstellung und daraus hergestellte arzneimittel |
JPS57156418A (en) * | 1981-03-19 | 1982-09-27 | Sumitomo Chem Co Ltd | Carcinostatic |
JPS5849315A (ja) * | 1981-09-18 | 1983-03-23 | Mitsui Pharmaceut Inc | 抗腫瘍剤 |
JPS58167589A (ja) * | 1982-03-26 | 1983-10-03 | Nissan Chem Ind Ltd | ピラゾ−ル誘導体、その製法および該誘導体を含有する除草剤 |
JPS58167598A (ja) * | 1982-03-29 | 1983-10-03 | Tanabe Seiyaku Co Ltd | アデノシン誘導体及びその製法 |
FR2536278A1 (fr) * | 1982-11-18 | 1984-05-25 | Dupont Michele | Nouvelle composition therapeutique utile notamment pour la cicatrisation des plaies |
DE3319282A1 (de) * | 1983-05-27 | 1984-11-29 | Gödecke AG, 1000 Berlin | Verwendung von adenosin bei der behandlung von herpes |
JPS59219235A (ja) * | 1983-05-30 | 1984-12-10 | Mitsui Toatsu Chem Inc | 消化性潰瘍用剤 |
DE3481191D1 (de) * | 1983-07-20 | 1990-03-08 | Teijin Ltd | Antineoplastisches mittel. |
JPS6028929A (ja) * | 1983-07-28 | 1985-02-14 | Hokuriku Seiyaku Co Ltd | 2’−デオキシグアノシンを有効成分とする消化性潰瘍治療剤 |
JPS6064907A (ja) * | 1983-09-17 | 1985-04-13 | Risuburan Prod:Kk | 水性ゲル状化粧料 |
JPS60126220A (ja) * | 1983-12-09 | 1985-07-05 | Otsuka Pharmaceut Factory Inc | 核酸成分組成物 |
FR2556727B1 (fr) * | 1983-12-19 | 1990-01-19 | Biostabilex Labo Pharma | Nouvelles compositions therapeutiques a base d'adn a haut poids moleculaire et leur procede de preparation |
JPS60174797A (ja) | 1984-02-21 | 1985-09-09 | Funai Corp | Ν−アロイルチミジン誘導体ならびに抗腫瘍活性物質の毒性低下剤 |
AU593271B2 (en) * | 1985-07-22 | 1990-02-08 | Teijin Limited | Antiviral treatments |
US4762823A (en) * | 1985-10-16 | 1988-08-09 | Sloan-Kettering Institute For Cancer Research | Nucleosides of 5-monofluoromethyluracil and 5-difluoromethyluracil |
ES2094718T3 (es) * | 1986-09-22 | 1997-02-01 | Janssen Pharmaceutica Nv | Antagonistas de la serotonine para el tratamiento de heridas. |
US4758533A (en) * | 1987-09-22 | 1988-07-19 | Xmr Inc. | Laser planarization of nonrefractory metal during integrated circuit fabrication |
US5246708A (en) * | 1987-10-28 | 1993-09-21 | Pro-Neuron, Inc. | Methods for promoting wound healing with deoxyribonucleosides |
JP2638949B2 (ja) * | 1988-07-06 | 1997-08-06 | トヨタ自動車株式会社 | 誘導電導機の制御方法 |
JPH0628929A (ja) * | 1992-07-09 | 1994-02-04 | Fujikura Ltd | 絶縁電線 |
JPH0634913A (ja) * | 1992-07-15 | 1994-02-10 | Oki Electric Ind Co Ltd | 密着イメージセンサの光学構成方法 |
JP3251060B2 (ja) * | 1992-08-18 | 2002-01-28 | 電気化学工業株式会社 | 窒化珪素粉末 |
JPH06123917A (ja) * | 1992-08-24 | 1994-05-06 | Fuji Photo Film Co Ltd | 写真作製装置 |
JP3454951B2 (ja) * | 1994-12-12 | 2003-10-06 | 株式会社半導体エネルギー研究所 | 半導体装置の作製方法 |
-
1988
- 1988-10-27 WO PCT/US1988/003824 patent/WO1989003838A1/en active IP Right Grant
- 1988-10-27 ZA ZA888083A patent/ZA888083B/xx unknown
- 1988-10-27 DE DE3855513T patent/DE3855513T2/de not_active Expired - Fee Related
- 1988-10-27 DE DE3856557T patent/DE3856557T2/de not_active Expired - Fee Related
- 1988-10-27 AT AT95203050T patent/ATE243039T1/de not_active IP Right Cessation
- 1988-10-27 EP EP88910239A patent/EP0355131B1/en not_active Expired - Lifetime
- 1988-10-27 CA CA000581430A patent/CA1329932C/en not_active Expired - Fee Related
- 1988-10-27 KR KR1019890701195A patent/KR890701609A/ko not_active IP Right Cessation
- 1988-10-27 EP EP95203050A patent/EP0712629B1/en not_active Expired - Lifetime
- 1988-10-27 AT AT88910239T patent/ATE142221T1/de not_active IP Right Cessation
- 1988-10-27 JP JP63509388A patent/JP2637534B2/ja not_active Expired - Fee Related
- 1988-10-28 IN IN754/MAS/88A patent/IN167609B/en unknown
- 1988-10-28 IL IL8820488A patent/IL88204A/en not_active IP Right Cessation
-
1989
- 1989-06-26 FI FI893100A patent/FI91764C/fi not_active IP Right Cessation
- 1989-06-26 NO NO892642A patent/NO174392C/no not_active IP Right Cessation
- 1989-06-27 DK DK198903180A patent/DK174400B1/da not_active IP Right Cessation
-
1993
- 1993-11-17 US US08/153,163 patent/US6020320A/en not_active Expired - Fee Related
-
1994
- 1994-03-16 FI FI941245A patent/FI97891C/fi not_active IP Right Cessation
- 1994-10-26 JP JP6299158A patent/JP2764014B2/ja not_active Expired - Lifetime
-
1998
- 1998-04-29 HK HK98103631A patent/HK1004854A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK174400B1 (da) | Acylderivater af deoxyribonucleosider og farmaceutiske præparater indeholdende disse | |
US6103701A (en) | Method for enhancing hematopoiesis with acyl deoxyribonucleosides | |
EP0339075B1 (en) | Acylated uridine and cytidine and uses thereof | |
KR100309194B1 (ko) | 항바이러스화합물 | |
EP0352477A2 (en) | Use of adenosine 5'-phosphat in the treatment of cancer cachexia | |
JP2006096772A (ja) | 造血改善のためのオキシプリンヌクレオシド、およびそれらの同族体、ならびにそのアシル誘導体 | |
US6348451B1 (en) | Acyl deoxyribonucleoside derivatives and uses thereof | |
NZ231718A (en) | Pharmaceutical composition comprising a 2',3'-dideoxypurine nucleoside and a purine nucleoside phosphorylase inhibitor | |
US6743782B1 (en) | Acyl deoxyribonucleoside derivatives and uses thereof | |
US7169765B1 (en) | Acyl deoxyribonucleoside derivatives and uses thereof | |
AU610315B2 (en) | Acyl deoxyribonucleoside derivatives and uses thereof | |
US20070254853A1 (en) | Compositions and Methods for Promotion of Wound Healing | |
KR920007395B1 (ko) | 아실 데옥시리보뉴클레오시드 유도체 및 그의 사용 | |
US4044122A (en) | Method of treating herpes virus hominis infections | |
MXPA98006743A (en) | Method and composition to inhibit irreversible cellular changes, due to tension |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PBP | Patent lapsed |
Country of ref document: DK |